-
Analyst Opinions
Business Travel Market Trends and Analysis by Passenger Flows, Destinations, Challenges, Opportunities and Case Studies, 2023 Update
Business Travel Market Overview The business travel market size was $197.23 billion in 2022 and will grow at a CAGR of more than 17% from 2022 to 2027. The performance of the business travel market in 2022 was positive, with the segment starting its recovery phase in earnest. There was a growing demand for business travel as corporations encouraged in-person meetings and conference attendance to help nurture business relationships. With many corporates operating a hybrid work policy, employees have started...
-
Company Profile
NewNurix Therapeutics Inc – Company Profile
Nurix Therapeutics Inc (Nurix Therapeutics), formerly Nurix Inc, is a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat cancer and autoimmune diseases. It is investigating NX-2127, a Bruton’s tyrosine kinase (BTK) inhibitor against B-cell malignancies; NX-5948 drug for the treatment of B-cell malignancies and autoimmune diseases; NX-1607, a ligase inhibitor for immune-oncology indications; and DeTIL-0255 program targeting tumor-infiltrating lymphocytes. The company is also evaluating KINASE-CTM3 against T-cell malignancies and autoimmune diseases; and COVID-CTMs for anti-viral infections....
Add to Basket -
Company Profile
NewCorporate Travel Management Ltd – Company Profile
Corporate Travel Management Ltd (CTML) is a provider of travel management solutions and services, which manages the purchase and delivery of travel services. The company offers travel solutions spanning corporate, events, sports travel, leisure, loyalty and wholesale travel services. It provides technical solutions through its CTM smart technology to travelers, travel bookers and managers. CTML offers platforms such as a travel portal, pre-trip approval, online booking tool, travel forecasting, mobile app, traveler tracking, travel risk alerts and reporting business intelligence....
Add to Basket -
Track & Monitor
PharmSource – M&A in the CMC Services Industry: Implications and Outlook
M&A is reshaping the bio/pharmaceutical contract development services industry. Established CMOs and CROs are pursuing acquisitions to drive scale and broaden their offerings, while private equity are anxious to either gain a presence in the industry or cash in on investments already made. Acquisitions of facilities divested by bio/pharma companies offer an alternative route for entering the industry or increasing capacity.